aa	amino acids
AAC	aminoglycoside acetyltransferase
ABC	ATP-binding cassette transporter system
APH	aminoglycoside phosphotransferase
Bp	base pair
CA-MRSA	community acquired MRSA
CC	clonal complex
CFU	colony forming unit
CLSI	Clinical and Laboratory Standards Institute
CNS	coagulase negative Staphylococci
DHA	drug:H+ antiporter
EF-G	elongation factor G
EUCAST	European Committee on Antimicrobial SusceptibilityTesting
GI	genomic island
GISA	glycopeptide intermediate S. aureus
GlcNAc	N-acetylglucosamine
GRSA	glycopeptide resistant S. aureus
GSSA	glycopeptide sensitive S. aureus
HA-MRSA	hospital acquired or health care acquired MRSA
h-GISA	heterogeneous glycopeptide intermediate S. aureus
h-VISA	heterogeneous vancomycin intermediate S. aureus
In	integron
IS	insertion sequence
LA-MRSA	livestock associated MRSA
MBC	minimal bactericidal concentration
MFS	major facilitator superfamily;
MIC	minimal inhibitory concentration
MIC50	MIC for 50% of strains tested
MIC90	MIC for 90% of strains tested
MLS-B	macrolide-lincosamides-streptogramin B
MLST	multilocus sequence typing
MPH	macrolide phosphotransferase
MRSA	methicillin resistant S. aureus
MSSA	methicillin sensitive S. aureus
MurNAc	N-acetylmuramic acid
orf	open reading frame
p	plasmid
PAI	pathogenicity island
PBP	penicillin binding protein
PFGE	pulse field gel electrophoresis
PVL	Panton–Valentine leukocidin
PMF	proton-motive force
RBS	ribosome binding site
RND	resistance-nodulation-cell division superfamily
RPPs	ribosomal protection proteins
S. aureus SCV	S. aureus small colony variants
SCCmec	staphylococcal chromosomal cassette mec
Spa	S. aureus protein A
ST	sequence type
TMS	transmembrane segments
TRSA	teicoplanin resistant S. aureus
Tn	transposon
VISA	vancomycin intermediate S. aureus
VRSA	vancomycin resistant S. aureus
VSSA	vancomycin sensitive S. aureus